These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 32881598

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93.
    Lan L, Liang Z, Zhao Y, Mo Y.
    Biosci Rep; 2020 Feb 28; 40(2):. PubMed ID: 31985002
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.
    Cheng X, Liu Z, Zhang H, Lian Y.
    Cell Cycle; 2021 Sep 28; 20(17):1663-1680. PubMed ID: 34334119
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1.
    Zhang B, Zhou M, Zou L, Miao J, Wang Y, Li Y, Lu S, Yu J.
    Biochem Biophys Res Commun; 2019 Jun 11; 513(4):827-833. PubMed ID: 31003776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F, Xu YH, Shen CC, Qin ZL, Zhou HB.
    Biomed Pharmacother; 2020 May 11; 125():109568. PubMed ID: 32058209
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA WWTR1-AS1 upregulates Notch3 through miR-136 to increase cancer cell stemness in cervical squamous cell carcinoma.
    Zhou X, Li Z, Li M.
    BMC Womens Health; 2024 Feb 08; 24(1):104. PubMed ID: 38331752
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q, Li H.
    Cancer Med; 2020 Jan 08; 9(2):689-699. PubMed ID: 31758653
    [Abstract] [Full Text] [Related]

  • 16. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
    Zhang P, Zhao F, Jia K, Liu X.
    Bioengineered; 2022 Feb 08; 13(2):2567-2584. PubMed ID: 35015607
    [Abstract] [Full Text] [Related]

  • 17. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH, Yu JH, Yang B, Gong FC, Zhang KW.
    Eur Rev Med Pharmacol Sci; 2019 Dec 08; 23(23):10400-10409. PubMed ID: 31841194
    [Abstract] [Full Text] [Related]

  • 18. LncRNA BLACAT1 Is Upregulated in Cervical Squamous Cell Carcinoma (CSCC) and Predicts Poor Survival.
    Cheng H, Tian J, Wang C, Ren L, Wang N.
    Reprod Sci; 2020 Feb 08; 27(2):585-591. PubMed ID: 32046460
    [Abstract] [Full Text] [Related]

  • 19. Targeted-regulating of miR-515-5p by LncRNA LOXL1-AS1 on the proliferation and migration of trophoblast cells.
    Zhang L, Wan Q, Zhou H.
    Exp Mol Pathol; 2021 Feb 08; 118():104588. PubMed ID: 33278425
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.